Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 4 Open-market sale Chief Medical Officer sold 919 shares at $15.00 ($13,785)
  2. 4 Open-market sale See Remarks sold 4,392 shares at $15.10 ($66,319)
  3. 4 Open-market sale Chief Medical Officer sold 21,669 shares at $15.00 ($325,035)
  4. 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $13.00 ($97,520)
  5. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $12.00 ($60,000)
  6. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.67 ($53,334)
  7. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.01 ($50,064)
  8. 4 Open-market sale Chief Scientific Officer sold 1,656 shares at $12.00 ($19,872)
  9. 4 Open-market sale Chief Scientific Officer sold 844 shares at $12.00 ($10,128)
  10. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.11 ($50,531)
  11. 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $13.42 ($100,631)
  12. 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $14.40 ($107,983)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Business Officer sold 5,415 shares at $16.07 ($87,019)
  16. 4 Open-market sale See Remarks sold 14,000 shares at an average $15.11 ($211,523)
  17. 4 Open-market sale Chief Scientific Officer sold 7,500 shares at $13.90 ($104,267)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 15 · 290 filings